Harpoon Therapeutics Buy Hold or Sell Recommendation

HARPDelisted Stock  USD 0.85  0.00  0.00%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Harpoon Therapeutics is 'Not Rated'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Harpoon Therapeutics given historical horizon and risk tolerance towards Harpoon Therapeutics. When Macroaxis issues a 'buy' or 'sell' recommendation for Harpoon Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Note, we conduct extensive research on individual companies such as Harpoon and provide practical buy, sell, or hold advice based on investors' constraints. Harpoon Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Execute Harpoon Therapeutics Buy or Sell Advice

The Harpoon recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Harpoon Therapeutics. Macroaxis does not own or have any residual interests in Harpoon Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Harpoon Therapeutics' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Harpoon TherapeuticsBuy Harpoon Therapeutics
Not Rated
For the selected time horizon Harpoon Therapeutics has a Risk Adjusted Performance of 0.0989, Jensen Alpha of 0.541, Total Risk Alpha of (0.17), Sortino Ratio of 0.1103 and Treynor Ratio of 4.89
We provide advice to complement the regular expert consensus on Harpoon Therapeutics. Our dynamic recommendation engine utilizes a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Harpoon Therapeutics is not overpriced, please check out all Harpoon Therapeutics fundamentals, including its revenue, cash flow from operations, current asset, as well as the relationship between the cash per share and beta . As Harpoon Therapeutics appears to be a penny stock we also urge to confirm its price to earning numbers.

Harpoon Therapeutics Trading Alerts and Improvement Suggestions

Harpoon Therapeutics is not yet fully synchronised with the market data
Harpoon Therapeutics has some characteristics of a very speculative penny stock
Harpoon Therapeutics has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 37.34 M. Net Loss for the year was (30.5 M) with loss before overhead, payroll, taxes, and interest of (49.48 M).
Harpoon Therapeutics currently holds about 90.15 M in cash with (69.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.72, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Over 83.0% of the company shares are owned by institutional investors

Harpoon Therapeutics Returns Distribution Density

The distribution of Harpoon Therapeutics' historical returns is an attempt to chart the uncertainty of Harpoon Therapeutics' future price movements. The chart of the probability distribution of Harpoon Therapeutics daily returns describes the distribution of returns around its average expected value. We use Harpoon Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Harpoon Therapeutics returns is essential to provide solid investment advice for Harpoon Therapeutics.
Mean Return
0.56
Value At Risk
-6.25
Potential Upside
9.59
Standard Deviation
4.78
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Harpoon Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Acquisition by Jonathan Drachman of 415 shares of Harpoon Therapeutics subject to Rule 16b-3 [view details]

Harpoon Therapeutics Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Harpoon . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Harpoon Therapeutics Buy or Sell Advice

When is the right time to buy or sell Harpoon Therapeutics? Buying financial instruments such as Harpoon Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Harpoon Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Books Thematic Idea Now

Books
Books Theme
Companies involved in publishing of books, newspapers, periodicals and other mass publications. The Books theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Books Theme or any other thematic opportunities.
View All  Next Launch
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Consideration for investing in Harpoon Stock

If you are still planning to invest in Harpoon Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Harpoon Therapeutics' history and understand the potential risks before investing.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine